George J Netto MD

Hivatkozott rá

	Összes	2020 óta
Hivatkozások	42343	20883
h-index	95	60
i10-index	365	285

4700

2350

1175

3525

2001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025174 193 255 254 344 349 330 335 398 478 616 972 1274 1680 2210 2640 2652 2692 2891 3514 3787 3920 4074 4645 898

Nyilvános hozzáférés

Összes megtekintése

153 cikk

11 cikk

elérhető

nem érhető el

Finanszírozási megbízások alapján

Társszerzők

Alcides Chaux, M.D.Dirección de Investigación y Vinculación con el Entorno, Universidad del Norte, ParaguayE-mail megerősítve itt: uninorte.edu.py
Jonathan EpsteinJohns Hopkins Medical InstitutionsE-mail megerősítve itt: jhmi.edu
Pedram ArganiProfessor of Pathology and Oncology, Johns Hopkins UniversityE-mail megerősítve itt: jhmi.edu
Angelo M. De Marzo M.D., Ph.D.Professor of Pathology, Urology and Oncology, The Johns Hopkins University School of MedicineE-mail megerősítve itt: jhmi.edu
Enrico MunariDepartment of Molecular and Translational Medicine, University of Brescia, Brescia, ItalyE-mail megerősítve itt: unibs.it
Hiroshi MiyamotoUniversity of Rochester Medical CenterE-mail megerősítve itt: urmc.rochester.edu
Sheila Friedrich FarajMédica patologista, ICESPE-mail megerősítve itt: hc.fm.usp.br
Mark SchoenbergProfessor & Chairman, Department of Urology, Albert Einstein College of Medicine and The MontefioreE-mail megerősítve itt: montefiore.org
Stephania Martins BezerraPatologista, AC Camargo Cancer CenterE-mail megerősítve itt: accamargo.org.br
Dr. Diana TaheriProfessor of Pathology, Head of Pathology Department, Isfahan university of Medical SciencesE-mail megerősítve itt: med.mui.ac.ir
Mohammad Obaidul Hoque, DDS. Ph.D.Associate Professor of Otolaryngoloy and Head & Neck Surgery, Urology and OncologyE-mail megerősítve itt: jhmi.edu
Peter ILLEIJohns Hopkins UniversityE-mail megerősítve itt: jhmi.edu
Tamara LotanProfessor and Deputy Director for Research, Department of Pathology, Johns Hopkins UniversityE-mail megerősítve itt: jhmi.edu
guido martignoniUniversity of VeronaE-mail megerősítve itt: univr.it
Michael Christoph HaffnerFred Hutchinson Cancer Research CenterE-mail megerősítve itt: fredhutch.org
Alexander BarasAssociate Professor of Pathology, Johns HopkinsE-mail megerősítve itt: jhmi.edu
Alan W. PartinJohns HopkinsE-mail megerősítve itt: jhmi.edu
Mohamad AllafJohns HopkinsE-mail megerősítve itt: jhmi.edu
Marie-Lisa EichPathology Resident, CharitéE-mail megerősítve itt: charite.de
William B. IsaacsProfessor of Urology and Oncology, Brady Urological Inst, Johns Hopkins Univ, School of MedicineE-mail megerősítve itt: jhmi.edu

Követés

George J Netto MD

University of Pennsylvania Perleman School of Medicine.

E-mail megerősítve itt: pennmedicine.upenn.edu

Pathology Urology Oncology Molecular Genetics


Cím Rendezés hivatkozások szerint Rendezés év szerint Rendezés cím szerint	Hivatkozott rá Hivatkozott rá	Év
Detection of circulating tumor DNA in early-and late-stage human malignancies C Bettegowda, M Sausen, RJ Leary, I Kinde, Y Wang, N Agrawal, ... Science translational medicine 6 (224), 224ra24-224ra24, 2014	5167	2014
Immune inhibitory molecules LAG-3 and PD-1 synergistically regulate T-cell function to promote tumoral immune escape SR Woo, ME Turnis, MV Goldberg, J Bankoti, M Selby, CJ Nirschl, ... Cancer research 72 (4), 917-927, 2012	1872	2012
TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal PJ Killela, ZJ Reitman, Y Jiao, C Bettegowda, N Agrawal, LA Diaz Jr, ... Proceedings of the National Academy of Sciences 110 (15), 6021-6026, 2013	1627	2013
UALCAN: An update to the integrated cancer data analysis platform DS Chandrashekar, SK Karthikeyan, PK Korla, H Patel, AR Shovon, ... Neoplasia 25, 18-27, 2022	1440	2022
Prostate cancer, version 2.2019, NCCN clinical practice guidelines in oncology JL Mohler, ES Antonarakis, AJ Armstrong, AV D’Amico, BJ Davis, T Dorff, ... Journal of the National Comprehensive Cancer Network 17 (5), 479-505, 2019	1321	2019
Androgen-induced TOP2B-mediated double-strand breaks and prostate cancer gene rearrangements MC Haffner, MJ Aryee, A Toubaji, DM Esopi, R Albadine, B Gurel, ... Nature genetics 42 (8), 668-675, 2010	694	2010
In breast carcinoma tissue, immature dendritic cells reside within the tumor, whereas mature dendritic cells are located in peritumoral areas D Bell, P Chomarat, D Broyles, G Netto, GM Harb, S Lebecque, ... Journal of Experimental Medicine 190 (10), 1417-1426, 1999	692	1999
LAG-3 regulates CD8⁺ T cell accumulation and effector function in murine self- and tumor-tolerance systems JF Grosso, CC Kelleher, TJ Harris, CH Maris, EL Hipkiss, A De Marzo, ... The Journal of clinical investigation 117 (11), 3383-3392, 2007	664	2007
Prevalence of the alternative lengthening of telomeres telomere maintenance mechanism in human cancer subtypes CM Heaphy, AP Subhawong, SM Hong, MG Goggins, EA Montgomery, ... The American journal of pathology 179 (4), 1608-1615, 2011	611	2011
The 2022 World Health Organization classification of tumours of the urinary system and male genital organs—part A: renal, penile, and testicular tumours H Moch, MB Amin, DM Berney, EM Compérat, AJ Gill, A Hartmann, ... European urology 82 (5), 458-468, 2022	509	2022
Global 5-hydroxymethylcytosine content is significantly reduced in tissue stem/progenitor cell compartments and in human cancers MC Haffner, A Chaux, AK Meeker, DM Esopi, J Gerber, LG Pellakuru, ... Oncotarget 2 (8), 627, 2011	494	2011
A distinctive subset of PEComas harbors TFE3 gene fusions P Argani, S Aulmann, PB Illei, GJ Netto, J Ro, H Cho, S Dogan, M Ladanyi, ... The American journal of surgical pathology 34 (10), 1395-1406, 2010	450	2010
PTEN protein loss by immunostaining: analytic validation and prognostic indicator for a high risk surgical cohort of prostate cancer patients TL Lotan, B Gurel, S Sutcliffe, D Esopi, W Liu, J Xu, JL Hicks, BH Park, ... Clinical cancer research 17 (20), 6563-6573, 2011	409	2011
NCCN guidelines insights: Prostate cancer, version 1.2021: Featured updates to the NCCN guidelines E Schaeffer, S Srinivas, ES Antonarakis, AJ Armstrong, JE Bekelman, ... Journal of the National Comprehensive Cancer Network 19 (2), 134-143, 2021	391	2021
Intravenous infusion of a replication-selective adenovirus (ONYX-015) in cancer patients: safety, feasibility and biological activity J Nemunaitis, C Cunningham, A Buchanan, A Blackburn, G Edelman, ... Gene therapy 8 (10), 746-759, 2001	372	2001
Rb loss is characteristic of prostatic small cell neuroendocrine carcinoma HL Tan, A Sood, HA Rahimi, W Wang, N Gupta, J Hicks, S Mosier, ... Clinical cancer research 20 (4), 890-903, 2014	366	2014
Prognostic value of p53 nuclear overexpression in patients with invasive bladder cancer treated with neoadjuvant MVAC. AS Sarkis, DF Bajorin, VE Reuter, HW Herr, G Netto, ZF Zhang, ... Journal of clinical oncology 13 (6), 1384-1390, 1995	334	1995
Long interspersed element-1 protein expression is a hallmark of many human cancers N Rodić, R Sharma, R Sharma, J Zampella, L Dai, MS Taylor, RH Hruban, ... The American journal of pathology 184 (5), 1280-1286, 2014	323	2014
Changing pattern of expression of the epidermal growth factor receptor and transforming growth factor alpha in the progression of prostatic neoplasms. HI Scher, A Sarkis, V Reuter, D Cohen, G Netto, D Petrylak, P Lianes, ... Clinical cancer research: an official journal of the American Association …, 1995	298	1995
TERT Promoter Mutations Occur Early in Urothelial Neoplasia and Are Biomarkers of Early Disease and Disease Recurrence in Urine I Kinde, E Munari, SF Faraj, RH Hruban, M Schoenberg, T Bivalacqua, ... Cancer research 73 (24), 7162-7167, 2013	296	2013

A rendszer jelenleg nem tudja elvégezni a műveletet. Próbálkozzon újra később.

Cikkek 1–20

Hivatkozások évente

Ismétlődő hivatkozások

Összevont hivatkozások

Társszerzők hozzáadásaTársszerzők

Követés

Hivatkozott rá

Társszerzők